The shift from “MIC-Only” back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance
ABSTRACT Carbapenem-resistant organisms (CROs) pose a major threat to global health due to limited therapeutic options and their capacity for rapid dissemination. Among these, carbapenemase-producing (CP) strains are of greatest concern, as they hydrolyze most β-lactams, and carbapenemase genes are...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology
2026-04-01
|
| Serija: | Journal of Clinical Microbiology |
| Teme: | |
| Online pristup: | https://journals.asm.org/doi/10.1128/jcm.00451-25 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|